{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:29:25Z","timestamp":1793053765948,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12017121"],"award-info":[{"award-number":["SHDC12017121"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871795"],"award-info":[{"award-number":["81871795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.intimp.2019.105826","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T12:21:37Z","timestamp":1566217297000},"page":"105826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["LDC000067 suppresses RANKL-induced osteoclastogenesis in vitro and prevents LPS-induced osteolysis in vivo"],"prefix":"10.1016","volume":"75","author":[{"given":"Song","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lin","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Zhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.105826_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"11","key":"10.1016\/j.intimp.2019.105826_bb0010","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.38794","article-title":"Inflammatory bone spur formation in psoriatic arthritis is different from bone spur formation in hand osteoarthritis","volume":"66","author":"Finzel","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"7515","key":"10.1016\/j.intimp.2019.105826_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13375","article-title":"miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2","volume":"512","author":"Krzeszinski","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2019.105826_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1359\/JBMR.051019","article-title":"Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease","volume":"21","author":"Colucci","year":"2006","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.intimp.2019.105826_bb0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00223-017-0373-1","article-title":"Bone loss in rheumatoid arthritis: basic mechanisms and clinical implications","volume":"102","author":"Shim","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.intimp.2019.105826_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bone.2018.01.012","article-title":"Bone matrix mcrodamage and vascular changes characterize bone marrow lesions in the subchondral bone of knee osteoarthritis","volume":"108","author":"Muratovic","year":"2018","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.intimp.2019.105826_bb0035","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00167-016-4113-2","article-title":"Bone marrow lesions and subchondral bone pathology of the knee","volume":"24","author":"Kon","year":"2016","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"issue":"3","key":"10.1016\/j.intimp.2019.105826_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ejo\/cji015","article-title":"Orthodontically induced root and alveolar bone resorption: inhibitory effect of systemic doxycycline administration in rats","volume":"27","author":"Mavragani","year":"2005","journal-title":"Eur. J. Orthod."},{"issue":"10","key":"10.1016\/j.intimp.2019.105826_bb0045","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1210\/endo.139.10.6331","article-title":"A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro","volume":"139","author":"Quinn","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2019.105826_bb0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejphar.2017.09.015","article-title":"Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2\/smad\/Akt\/Runx2 signaling pathway","volume":"815","author":"Li","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2019.105826_bb0055","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbrc.2018.10.100","article-title":"Rubiadin-1-methyl ether from Morinda officinalis how. Inhibits osteoclastogenesis through blocking RANKL-induced NF-kappaB pathway","volume":"506","author":"He","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2019.105826_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.intimp.2017.05.029","article-title":"Sciadopitysin suppresses RANKL-mediated osteoclastogenesis and prevents bone loss in LPS-treated mice","volume":"49","author":"Cao","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2019.105826_bb0065","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1002\/jcb.26105","article-title":"Picroside II inhibits RANKL-mediated osteoclastogenesis by attenuating the NF-kappaB and MAPKs signaling pathway in vitro and prevents bone loss in lipopolysaccharide treatment mice","volume":"118","author":"Yang","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2019.105826_bb0070","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1002\/jcp.28079","article-title":"Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL-induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling","volume":"234","author":"Xiao","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.intimp.2019.105826_bb0075","doi-asserted-by":"crossref","first-page":"20944","DOI":"10.1002\/jcp.28699","article-title":"LY411575, a potent gamma-secretase inhibitor, suppresses osteoclastogenesis in vitro and LPS-induced calvarial osteolysis in vivo","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2019.105826_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-198121040-00002","article-title":"Pharmacology and therapeutic use of calcitonin","volume":"21","author":"Stevenson","year":"1981","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.intimp.2019.105826_bb0085","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1535-7163.MCT-14-0253","article-title":"Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis","volume":"13","author":"Duong","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.intimp.2019.105826_bb0090","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2174\/1381612822666160122093810","article-title":"Pathophysiology of metastatic bone disease and the role of the second generation of bisphosphonates: from basic science to medicine","volume":"22","author":"F. Barghash","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2019.105826_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jep.2016.05.025","article-title":"Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery","volume":"189","author":"Zhang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.105826_bb0100","doi-asserted-by":"crossref","first-page":"31441","DOI":"10.1038\/srep31441","article-title":"Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis","volume":"6","author":"Hellvard","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2019.105826_bb0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/ATVBAHA.110.213934","article-title":"Flavopiridol protects against inflammation by attenuating leukocyte-endothelial interaction via inhibition of cyclin-dependent kinase 9","volume":"31","author":"Schmerwitz","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105826_bb0110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/art.38378","article-title":"Cyclin-dependent kinase 9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines","volume":"66","author":"Yik","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2019.105826_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1389450119666181026152221","article-title":"CDK9 as an appealing target for therapeutic interventions","volume":"20","author":"Eyvazi","year":"2019","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.intimp.2019.105826_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bph.12408","article-title":"Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor","volume":"171","author":"Albert","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105826_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2019.07.032","article-title":"CDK9 attenuation exerts protective effects on catabolism and hypertrophy in chondrocytes and ameliorates osteoarthritis development","volume":"517","author":"Xue","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2019.105826_bb0130","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1111\/jcmm.13674","article-title":"Oxymatrine exerts protective effects on osteoarthritis via modulating chondrocyte homoeostasis and suppressing osteoclastogenesis","volume":"22","author":"Jiang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.intimp.2019.105826_bb0135","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.bbadis.2017.08.009","article-title":"BRD4 has dual effects on the HMGB1 and NF-kappaB signalling pathways and is a potential therapeutic target for osteoarthritis","volume":"1863","author":"Jiang","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.intimp.2019.105826_bb0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fphar.2018.00174","article-title":"Flavopiridol protects bone tissue by attenuating RANKL induced osteoclast formation","volume":"9","author":"Hu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105826_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \"cherubism\" mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"issue":"7722","key":"10.1016\/j.intimp.2019.105826_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"issue":"7507","key":"10.1016\/j.intimp.2019.105826_bb0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13484","article-title":"Structural basis for lipopolysaccharide insertion in the bacterial outer membrane","volume":"511","author":"Qiao","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.intimp.2019.105826_bb0160","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1292\/jvms.17-0393","article-title":"Chronological differential effects of pro-inflammatory cytokines on RANKL-induced osteoclast differentiation of canine bone marrow-derived macrophages","volume":"79","author":"Wijekoon","year":"2017","journal-title":"J. Vet. Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2019.105826_bb0165","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jbmr.2710","article-title":"Alexidine dihydrochioride attenuates osteoclast formation and bone resorption and protects against LPS-induced osteolysis","volume":"31","author":"Zhu","year":"2016","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.intimp.2019.105826_bb0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/jcb.26293","article-title":"CDK9: a key player in cancer and other diseases","volume":"119","author":"Franco","year":"2018","journal-title":"J. Cell. Biochem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919312883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919312883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:42:18Z","timestamp":1762551738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919312883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":34,"alternative-id":["S1567576919312883"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105826","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDC000067 suppresses RANKL-induced osteoclastogenesis in vitro and prevents LPS-induced osteolysis in vivo","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105826"}}